Literature DB >> 11175798

Psoriasis: the plot thickens....

M P Schön, T Ruzicka.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11175798     DOI： 10.1038/84293

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  11 in total

1.  Cutting edge: rapid accumulation of epidermal CCL27 in skin-draining lymph nodes following topical application of a contact sensitizer recruits CCR10-expressing T cells.

Authors:  Victor Huang; Anke S Lonsdorf; Lei Fang; Takashi Kakinuma; Vivian C Lee; Emily Cha; Hong Zhang; Keisuke Nagao; Marzanna Zaleska; Waldemar L Olszewski; Sam T Hwang
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

Review 2.  Immunopathogenic mechanisms in psoriasis.

Authors:  J E Gudjonsson; A Johnston; H Sigmundsdottir; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

Review 3.  The Inflammatory Response in Psoriasis: a Comprehensive Review.

Authors:  Yaxiong Deng; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

4.  Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation.

Authors:  Koichi Yanaba; Masahiro Kamata; Nobuko Ishiura; Sayaka Shibata; Yoshihide Asano; Yayoi Tada; Makoto Sugaya; Takafumi Kadono; Thomas F Tedder; Shinichi Sato
Journal:  J Leukoc Biol       Date:  2013-04-29       Impact factor: 4.962

Review 5.  Cutaneous T-cell lymphoma: roles for chemokines and chemokine receptors.

Authors:  Xue-Song Wu; Anke S Lonsdorf; Sam T Hwang
Journal:  J Invest Dermatol       Date:  2009-02-26       Impact factor: 8.551

6.  Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation.

Authors:  Daniela Bruch-Gerharz; Oliver Schnorr; Christoph Suschek; Karl-Friedrich Beck; Josef Pfeilschifter; Thomas Ruzicka; Victoria Kolb-Bachofen
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

7.  Dendritic cells activated by IFN-γ/STAT1 express IL-31 receptor and release proinflammatory mediators upon IL-31 treatment.

Authors:  Jutta Horejs-Hoeck; Harald Schwarz; Sebastian Lamprecht; Elisabeth Maier; Stefan Hainzl; Maria Schmittner; Gernot Posselt; Angelika Stoecklinger; Thomas Hawranek; Albert Duschl
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

8.  LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment.

Authors:  Muhammad Anas Kamleh; Stuart G Snowden; Dmitry Grapov; Gavin J Blackburn; David G Watson; Ning Xu; Mona Ståhle; Craig E Wheelock
Journal:  J Proteome Res       Date:  2014-11-12       Impact factor: 4.466

9.  Therapeutic efficacy and immunological response of CCL5 antagonists in models of contact skin reaction.

Authors:  Miriam Canavese; Fiorella Altruda; Lorenzo Silengo
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

Review 10.  The role of dendritic cells in the immunopathogenesis of psoriasis.

Authors:  Sunit P Jariwala
Journal:  Arch Dermatol Res       Date:  2007-08-07       Impact factor: 3.017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.